weighing <10 kg or alternate-day glucocorticoid therapy (i.e., "low-level immunosuppression" For neonates/infants with second-and/or third-trimester antenatal exposure to rituximab, delaying live attenuated rotavirus vaccine until >6 months of age is conditionally recommended. Vaccination against rotavirus typically occurs at 2 and 4 months, or at 2, 4, and 6 months. Rotavirus is rare in the US because of widespread immunization, and for this reason, the AAP recommends delaying rotavirus